General Information
Drug ID
DR01327
Drug Name
Abiraterone acetate
Synonyms
CB-7630; JNJ-212082; Zytiga
Drug Type
Small molecular drug
Indication Prostate cancer [ICD11: 2C82] Approved [1]
Therapeutic Class
Anticancer Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=9821849"></iframe>
3D MOL 2D MOL
Formula
C26H33NO2
Canonical SMILES
CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
InChI
InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1
InChIKey
UVIQSJCZCSLXRZ-UBUQANBQSA-N
CAS Number
CAS 154229-18-2
Pharmaceutical Properties Molecular Weight 391.555 Topological Polar Surface Area 39.2
Heavy Atom Count 29 Rotatable Bond Count 3
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 3
PubChem CID
9821849
ChEBI ID
CHEBI:68639
TTD Drug ID
D06CNP
DT(s) Transporting This Drug OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [2]
References
1 Abiraterone acetate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer. Prostate. 2017 May;77(13):1303-1311.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.